Bellevue Group’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106M | Buy |
1,985,272
+734,606
| +59% | +$39.2M | 2.33% | 13 |
|
|
2025
Q1 | $50.6M | Buy |
+1,250,666
| New | +$50.6M | 1.13% | 22 |
|
|
2023
Q4 | – | Sell |
-25,000
| Closed | -$1.26M | – | 162 |
|
|
2023
Q3 | $1.26M | Sell |
25,000
-2,100
| -8% | -$106K | 0.02% | 121 |
|
|
2023
Q2 | $1.27M | Buy |
27,100
+1,000
| +4% | +$46.7K | 0.02% | 123 |
|
|
2023
Q1 | $999K | Sell |
26,100
-16,550
| -39% | -$633K | 0.01% | 129 |
|
|
2022
Q4 | $2.34M | Buy |
42,650
+1,016
| +2% | +$55.7K | 0.03% | 123 |
|
|
2022
Q3 | $1.42M | Buy |
+41,634
| New | +$1.42M | 0.02% | 129 |
|